These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 9798607

  • 21. Malignant hyperthermia susceptibility: anaesthetic implications and risk stratification.
    Ben Abraham R, Cahana A, Krivosic-Horber RM, Perel A.
    QJM; 1997 Jan; 90(1):13-8. PubMed ID: 9093584
    [Abstract] [Full Text] [Related]

  • 22. Evidence for a spontaneous C1840-T mutation in the RYR1 gene after DNA fingerprinting in a malignant hyperthermia susceptible family.
    Steinfath M, Seranski P, Singh S, Fiege M, Wappler F, Schulte Am Esch J, Scholz J.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):372-5. PubMed ID: 12237752
    [Abstract] [Full Text] [Related]

  • 23. [Malignant hyperthermia].
    Zimprich F, Kress HG, Zeitlhofer J.
    Wien Klin Wochenschr; 2003 Sep 15; 115(15-16):556-62. PubMed ID: 14531168
    [Abstract] [Full Text] [Related]

  • 24. Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia.
    Galli L, Orrico A, Lorenzini S, Censini S, Falciani M, Covacci A, Tegazzin V, Sorrentino V.
    Hum Mutat; 2006 Aug 15; 27(8):830. PubMed ID: 16835904
    [Abstract] [Full Text] [Related]

  • 25. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.
    Riazi S, Larach MG, Hu C, Wijeysundera D, Massey C, Kraeva N.
    Anesth Analg; 2014 Feb 15; 118(2):381-387. PubMed ID: 23842196
    [Abstract] [Full Text] [Related]

  • 26. Dantrolene--a review of its pharmacology, therapeutic use and new developments.
    Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F.
    Anaesthesia; 2004 Apr 15; 59(4):364-73. PubMed ID: 15023108
    [Abstract] [Full Text] [Related]

  • 27. Is there a link between malignant hyperthermia and exertional heat illness?
    Muldoon S, Deuster P, Brandom B, Bunger R.
    Exerc Sport Sci Rev; 2004 Oct 15; 32(4):174-9. PubMed ID: 15604937
    [Abstract] [Full Text] [Related]

  • 28. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.
    Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB.
    Anesth Analg; 2010 Feb 01; 110(2):498-507. PubMed ID: 20081135
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Novel double and single ryanodine receptor 1 variants in two Austrian malignant hyperthermia families.
    Kaufmann A, Kraft B, Michalek-Sauberer A, Weindlmayr M, Kress HG, Steinboeck F, Weigl LG.
    Anesth Analg; 2012 May 01; 114(5):1017-25. PubMed ID: 22415532
    [Abstract] [Full Text] [Related]

  • 34. Delayed onset of malignant hyperthermia in the intensive care unit: a rare but life-threatening disorder.
    Twine N.
    Crit Care Nurs Q; 2013 May 01; 36(2):213-7. PubMed ID: 23470706
    [Abstract] [Full Text] [Related]

  • 35. Suspected malignant hyperthermia in a child with laminin alpha2 (merosin) deficiency in the absence of a triggering agent.
    Shukry M, Guruli ZV, Ramadhyani U.
    Paediatr Anaesth; 2006 Apr 01; 16(4):462-5. PubMed ID: 16618304
    [Abstract] [Full Text] [Related]

  • 36. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV, Quane KA, Lynch PJ.
    Hum Mutat; 2000 Apr 01; 15(5):410-7. PubMed ID: 10790202
    [Abstract] [Full Text] [Related]

  • 37. Malignant hyperthermia and central core disease causative mutations in Swedish patients.
    Broman M, Islander G, Müller CR, Ranklev-Twetman E.
    Acta Anaesthesiol Scand; 2007 Jan 01; 51(1):50-3. PubMed ID: 17081152
    [Abstract] [Full Text] [Related]

  • 38. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs.
    Schütte JK, Becker S, Burmester S, Starosse A, Lenz D, Kröner L, Wappler F, Gerbershagen MU.
    Eur J Anaesthesiol; 2011 Apr 01; 28(4):256-64. PubMed ID: 21513076
    [Abstract] [Full Text] [Related]

  • 39. [A case of malignant hyperthermia without hyperthermia].
    Muiños PA, Ortells MA, Sánchez G, Carrasco MS.
    Rev Esp Anestesiol Reanim; 1995 Dec 01; 42(10):436. PubMed ID: 8789530
    [No Abstract] [Full Text] [Related]

  • 40. A report of fulminant malignant hyperthermia in a patient with a novel mutation of the CACNA1S gene.
    Toppin PJ, Chandy TT, Ghanekar A, Kraeva N, Beattie WS, Riazi S.
    Can J Anaesth; 2010 Jul 01; 57(7):689-93. PubMed ID: 20431982
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.